KCC Shared Top Border

Familial Adenomatous Polyposis


Colorectal cancer is one of the most common malignant diseases.  Many colorectal cancers originate from benign adenomas as in as in case of Familial Adenomatous Polyposis (FAP).  FAP has an incidence of approximately 1:10,000 and is an autosomal dominant disorder with high penetrance and highly variable expressivity.  The genetic defect is characterized by the development of numerous (one hundred to several thousand) colorectal polyps.  The age of onset of these polyps is variable but usually develop in the second or third decade of life.  The likelihood that they will develop colorectal cancer is almost 100% unless they are treated by prophylactic colectomy.

Polyps may occur in the upper gastrointestinal tract through risk of malignant transformation is lower than for colonic adenomas.  Extraintestinal manifestations of the disease include epidermoid cysts, ostemas, desmoid tumors and congenital hypertrophy of the retinal pigment epithelium (CHRPE).

The gene responsible for the disease is APC (adenomatous polyposis coli) located at 5q21-22.  About 200 different germline mutations in the APC gene have been described.  Most of the mutations lead to the termination of the protein chain. The APC gene consists of 15 exons with an open reading frame larger than 8.5kb, so it is difficult to screen or sequence this rapidly.

Methodology


Protein Truncation Test (PTT) detects mutations at the protein level rather than the DNA level.  The DNA is first transcribe into messenger RNA and then translated into peptide chain.  Mutational changes (bases changes resulting into nonsense or stop codons) prematurely terminate translation and produce a truncated protein which is smaller than the normal size protein.  Since majority of the mutations (greater than 85%) in the APC gene are associated with inherited form of colon cancer and result in protein truncation, the PTT test is being used as a direct test for mutation detection.

 

References

            Ward, J.T. et al. Genomics 17:15 (1993)

            Lynch, H.T. et al Cancer Gen. Cyto. 93:84 (1997)

            Powell, S.M.et al N.Engl.J.Med. 329:1982 (1993)

 

Shared Bottom Border

PLEASE NOTE:
The Kimmel Cancer Center Web site, its content and programs, is provided for informational and educational purposes only and is not intended as medical advice, nor is it intended to create any physician-patient relationship.  Please remember that this information should not substitute for a visit or consultation with a health care provider.  The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please send comments to: webmaster@kimmelcancercenter.org. All contents copyright © 2002 Thomas Jefferson University. All rights reserved.